Ansa Biotechnologies, Inc.的封面图片
Ansa Biotechnologies, Inc.

Ansa Biotechnologies, Inc.

生物技术研究

Emeryville,California 8,154 位关注者

High-fidelity DNA synthesis using enzymes

关于我们

At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability. Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page.

网站
https://www.ansabio.com
所属行业
生物技术研究
规模
11-50 人
总部
Emeryville,California
类型
私人持股
创立
2018
领域
DNA

地点

  • 主要

    1198 65th St

    Suite 250

    US,California,Emeryville,94608

    获取路线

Ansa Biotechnologies, Inc.员工

动态

  • Our co-founder reflects on a great day visiting the grad school lab that inspired Ansa's game-changing DNA synthesis technology. It must be so fulfilling to give back to the place that started it all!

    查看Sebastian Palluk的档案

    CTO at Ansa Biotechnologies, Inc

    Daniel Lin-Arlow and I stared working on DNA synthesis in grad school because we saw our labmates in the Keasling Lab struggle to get the DNA constructs they needed for their experiments. They had amazing ideas for how to engineer microbes that could sustainably manufacture chemicals, but so many projects got stalled, delayed, or cancelled due to DNA synthesis problems. Nearly ten years after we started working together on new methods for DNA synthesis in the Keasling Lab, and 6 years after spinning out Ansa Biotechnologies, Inc., we've built a DNA synthesis platform that can finally make a big impact on the world. Our platform can reliably build sequences that are very difficult or even impossible for other DNA synthesis companies to manufacture. These types of sequences are not just oddball curiosities; they're essential for the next generation of biological engineering applications. Therefore it was incredibly fulfilling to hand-deliver six complex DNA constructs encoding engineered polyketide synthase enzymes to our former grad school lab, our inspiration, and where this all began. The constructs were designed to instruct microbes to sustainably produce valuable chemicals. The lab was struggling to obtain these constructs from conventional sources, and we're proud to say that our platform successfully produced them all on the first try! We also joined current lab members for a fireside chat about our journey starting a company after grad school. It was a great day. Thanks to Jay Keasling for the invite!

    • 该图片无替代文字
    • 该图片无替代文字
  • ?? Natural curiosity can get you far in #STEM, and having confidence in your abilities is also key. "Don’t downplay your accomplishments and make sure to take pride in the work you have done." These wise words from Sr Research Associate Melissa Thornton should resonate with anyone pursuing a career in science, but she's hoping they hit home with women and others who may be underrepresented in the field. We're shining a spotlight on Melissa as part of our continued celebration of #WomeninSTEM this month. ???? Thanks for sharing your insights, Melissa!? #WomenInScience #STEMLeadership #WomensHistoryMonth #BreakingBarriers #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #complexDNA? #customDNA?

    • 该图片无替代文字
  • Scientific research is built on bold and loud moves. But women are often expected to be neither. For #InternationalWomensDay, we celebrate women who challenge expectations and shape the future of science—on their own terms. Ania Wronski, Ph.D. is one of them. Our Director of Technical Support has had to navigate many intimidating, male-dominated spaces in her career. Along the way, she learned that boldness isn’t about being loud—it’s about believing in your ability to adapt, lead, and grow. You will never have all the data you need to make a decision, she says, but you have to trust in your process and what you have to help you through. See what else she shared about her journey and her advice for other young #WomeninSTEM. #WomenInScience #STEMLeadership #IWD2025 #BreakingBarriers #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #complexDNA? #customDNA?

    • 该图片无替代文字
  • When the Gao lab needed to generate some repetitive protein sequences in order to create and optimize engineered cells via RNA delivery, they couldn't rely on their typical cloning workflow. And when they tried to get the sequences synthesized elsewhere, they were told it couldn't be done. Enter Ansa. Within a week, on the first try, the Ansa team was to able to deliver. Hear more about the project and how the lab overcame several challenges and improved its workflow in this webinar with lab member Connor C.. ?? Watch now, on demand: https://lnkd.in/eb9NFWtH #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA? #customDNA #AnsamerAnswers #RELEASE #webinar #genetics #RNAtherapeutics

  • 查看Ansa Biotechnologies, Inc.的组织主页

    8,154 位关注者

    ?? We’re hiring a Director of Product Management! ?? At Ansa Biotechnologies, we are transforming life science research with our innovative approach to DNA synthesis. We are seeking a driven and dedicated Director of Product Management to join our dynamic team at the forefront of synthetic biology. In this role, you will be responsible for guiding the development and launch of innovative products that meet customer needs and drive business growth. If you’re passionate about pushing the boundaries of science, making a global impact, and joining a culture of innovation, apply to join our team! https://lnkd.in/g4tDCwmP

  • Ansa Biotechnologies, Inc.转发了

    查看Jason T. Gammack的档案

    Chief Executive Officer at Ansa Biotechnologies

    Science moves fast—so why is DNA synthesis stuck in the slow lane? Long turnaround times, failed orders, and delays shouldn’t be the price of admission for researchers pushing the boundaries of cell and gene therapy. As Dan points out in this Medicine Maker piece, “we cannot realize the full potential of cell and gene therapies without being able to explore a broader design space – and reliably get the actual DNA we want to test all of those interesting ideas.” That’s exactly why we’re shaking things up at Ansa Biotechnologies, Inc. Because bad DNA synthesis shouldn’t be holding back great science. Give this a read!

    查看Ansa Biotechnologies, Inc.的组织主页

    8,154 位关注者

    Designing gene sequences on a computer is one thing. Actually making them is another. Construction of DNA molecules longer than a few hundred base pairs can be a daunting, if not impossible task, especially when they include challenging elements like repeats or complex guanine-cytosine (GC) content. Ansa co-founder and CSO, Daniel Lin-Arlow shares his insights and advice for scientists on how to overcome some of the challenges of DNA synthesis, including complexity, turnaround time & quality control. ?? Read The Medicine Maker article:? https://lnkd.in/eQSprrA3 #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA? #customDNA #AnsamerAnswers

    • 该图片无替代文字
  • Designing gene sequences on a computer is one thing. Actually making them is another. Construction of DNA molecules longer than a few hundred base pairs can be a daunting, if not impossible task, especially when they include challenging elements like repeats or complex guanine-cytosine (GC) content. Ansa co-founder and CSO, Daniel Lin-Arlow shares his insights and advice for scientists on how to overcome some of the challenges of DNA synthesis, including complexity, turnaround time & quality control. ?? Read The Medicine Maker article:? https://lnkd.in/eQSprrA3 #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA? #customDNA #AnsamerAnswers

    • 该图片无替代文字
  • Ansa Biotechnologies, Inc.转发了

    查看Jared Ellefson的档案

    Next-Gen DNA Synthesis at Ansa Bio

    Some folks were surprised when I left academia back in 2018 to co-found a company focused on DNA synthesis. "Gene synthesis and cloning technologies? Aren't those just boring tools, a means to an end?" Well, 6.5 years later, I can tell you it's been anything but boring - and the excitement is only growing. Let me take you back: In my early grad school days, before gblocks and Gibson assembly, building custom plasmids could be a months-long odyssey. Even as the field evolved with companies like Twist leveraging million-oligo printers and machine learning, fundamental challenges persisted - delayed orders, sequence restrictions, and endless cloning. Then came the turning point: reading my future co-founders Dan and Sebastian's Nature Biotechnology paper on enzymatic oligo synthesis. With my background in high-throughput polymerase engineering, I saw the potential. The hypothesis was simple yet powerful: enzymes could outperform chemistry in DNA synthesis. And considering that DNA synthesis underpins virtually every advancement in pharma and biotech, even a 5% improvement in research efficiency could be transformative. Today, we've turned that vision into reality at Ansa. We're producing the world's highest quality and longest oligos, enabling our customers to access complex DNA sequences that were previously out of reach. But what truly excites me? This is just the beginning. We're rapidly innovating to make DNA synthesis so reliable that researchers will never have to see it as a bottleneck again. Sometimes the most exciting innovations come from reimagining the fundamentals. Who knew "boring" could be so revolutionary? Check us out @ ansabio.com

    • 该图片无替代文字
  • Don't miss the Genomics Showcase Fair today at the Mission Bay Conference Center! Drop by the Ansa Biotechnologies table where you can learn how to accelerate your research by letting us synthesize your most complex DNA sequences.

    查看Bio-EV的组织主页

    445 位关注者

    Tomorrow, January 28th, we return to the Mission Bay Conference Center for the Genomics Showcase Fair 2025. Come join us!

    • 该图片无替代文字
  • ??? Charting new territory in DNA synthesis requires a highly motivated, multidisciplinary team and a culture of innovation where people don’t feel constrained by staying in their lanes. Ansa co-founder and CSO Daniel Lin-Arlow talks about how this approach has helped Ansa come up with some creative solutions to complex challenges, starting with a new “dipping” method used in our synthesizers, in our latest blog: how:https://lnkd.in/eKhdjpHs #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA? #customDNA

    • 该图片无替代文字

相似主页

查看职位

融资